Danish BioTech company Samplix, which develops droplet microfluidics technology for functional single-cell analysis, has announced a €25 million first close of a financing round. The Round Only...
Silvia Bio, a University of Sheffield biotechnology spinout focused on improving the manufacturing of complex biological medicines, has raised £3 million in Seed funding. The...
Basel-based Nouscom, a clinical-stage BioTech focused on cancer interception and next-generation immunotherapies, has closed an oversubscribed €120 million ($135 million) Series D round to advance an investigational...
Munich, Germany – September 2026 — The biopharmaceutical industry is navigating a changing deal environment, with companies reassessing pipelines, seeking external innovation and exploring...
UK BioTech company OMass Therapeutics, which develops small-molecule therapeutics against highly validated target ecosystems, has announced an oversubscribed €275 million (£230 million) Series C round. The Round...
Paris-based BioTech company WhiteLab Genomics, which uses AI to design the building blocks of genomic medicines, has closed a €23.2 million ($26 million) Series B funding round....
Paris-based BioTech and AI company Rivercell, which is building proprietary cell-response data infrastructure and a world model that predicts how human cells respond to treatment,...
Gothenburg-based Aventix AB, a bioanalytics company building sensor-based analytical tools for laboratories, has raised €1.2 million ($1.35M) in pre-seed financing. The company is founded by serial entrepreneurs...